{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:45:47Z","timestamp":1791305147221,"version":"4.3.1"},"reference-count":31,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T00:00:00Z","timestamp":1520985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["American J Hematol"],"published-print":{"date-parts":[[2018,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Carmustine shortage has led to an increase use of alternative conditioning regimens prior to autologous stem cell transplantation for the treatment of lymphoma, including Bendamustine\u2010based (BeEAM). The aim of this study was to evaluate the safety of the BeEAM regimen in a large cohort of patients. A total of 474 patients with a median age of 56 years were analyzed. The majority of patients had diffuse large B\u2010cell lymphoma (43.5%). Bendamustine was administered at a median dose of 197 mg\/m<jats:sup>2<\/jats:sup>\/day (50\u2010250) on days\u20107 and \u22126. The observed grade 1\u20104 toxicities included mucositis (83.5%), gastroenteritis (53%), skin toxicity (34%), colitis (29%), liver toxicity (19%), pneumonitis (5%), and cardiac rhythm disorders (4%). Nonrelapse mortality (NRM) was reported in 3.3% of patients. Acute renal failure (ARF) was reported in 132 cases (27.9%) (G \u22652; 12.3%). Organ toxicities and death were more frequent in patients with post conditioning renal failure. In a multivariate analysis, pretransplant chronic renal failure, bendamustine dose &gt;160 mg\/m<jats:sup>2<\/jats:sup> and age were independent prognostic factors for ARF. Pretransplant chronic renal failure, hyperhydration volume, duration of hyperhydration, and etoposide dose were predictive factors of NRM. A simple, four\u2010point scoring system can stratify patients by levels of risk for ARF and may allow for a reduction in the bendamustine dose to avoid toxicity. Drugs shortage may have dangerous consequences. Prospective, comparative studies are needed to confirm the toxicity\/efficacy extents from this conditioning regimen compared to other types of high dose therapy.<\/jats:p>","DOI":"10.1002\/ajh.25077","type":"journal-article","created":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T07:28:20Z","timestamp":1519370900000},"page":"729-735","source":"Crossref","is-referenced-by-count":38,"title":["Bendamustine\u2010based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers"],"prefix":"10.1002","volume":"93","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0457-2252","authenticated-orcid":false,"given":"Sylvain P.","family":"Chantepie","sequence":"first","affiliation":[{"name":"Institut d'H\u00e9matologie de Basse\u2010Normandie, CHU Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Garciaz","sequence":"additional","affiliation":[{"name":"Department of Hematology Institut Paoli Calmettes Marseille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Tchernonog","sequence":"additional","affiliation":[{"name":"Department of Clinical Hematology University Hospital Montpellier Montpellier France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Peyrade","sequence":"additional","affiliation":[{"name":"Hematology Department Centre Antoine Lacassagne Nice France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie\u2010Virginie","family":"Larcher","sequence":"additional","affiliation":[{"name":"Hematology, Toulouse University Hospital Toulouse France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momar","family":"Diouf","sequence":"additional","affiliation":[{"name":"Clinical Research Department Amiens University hospital Amiens EA4666 France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u2010Mathieu","family":"Fornecker","sequence":"additional","affiliation":[{"name":"Haematology, University Hospital Strasbourg France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roch","family":"Houot","sequence":"additional","affiliation":[{"name":"Hematology, University hospital Rennes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Gastinne","sequence":"additional","affiliation":[{"name":"Department of Hematology Nantes University Hospital Nantes France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Soussain","sequence":"additional","affiliation":[{"name":"Department of Hematology Curie Institute, H\u00f4pital Ren\u00e9 Huguenin Saint\u2010Cloud France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Malak","sequence":"additional","affiliation":[{"name":"Department of Hematology Curie Institute, H\u00f4pital Ren\u00e9 Huguenin Saint\u2010Cloud France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Lemal","sequence":"additional","affiliation":[{"name":"Service d'h\u00e9matologie clinique adulte et de th\u00e9rapie cellulaire, CHU ESTAING, EA 7453 CHELTER, Universit\u00e9 Clermont Auvergne CIC\u2010501 Clermont\u2010Ferrand France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Delette","sequence":"additional","affiliation":[{"name":"Oncopole Hopital Sud Amiens FRA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Ibrahim","sequence":"additional","affiliation":[{"name":"Makassed General Hospital Beirut LBN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne\u2010Claire","family":"Gac","sequence":"additional","affiliation":[{"name":"Institut d'H\u00e9matologie de Basse\u2010Normandie, CHU Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Reboursi\u00e8re","sequence":"additional","affiliation":[{"name":"Institut d'H\u00e9matologie de Basse\u2010Normandie, CHU Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean\u2010Pierre","family":"Vilque","sequence":"additional","affiliation":[{"name":"Institut d'H\u00e9matologie de Basse\u2010Normandie, Centre Fran\u00e7ois Baclesse Caen France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed\u2010Amine","family":"Bekadja","sequence":"additional","affiliation":[{"name":"Hematology and Cell Therapy Etablissement Hospitalier Universitaire (EHU) 1st November Oran Algeria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene\u2010Olivier","family":"Casasnovas","sequence":"additional","affiliation":[{"name":"Hematology, University Hospital Dijon France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remy","family":"Gressin","sequence":"additional","affiliation":[{"name":"Hematology, CHU Grenoble Grenoble France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Guidez","sequence":"additional","affiliation":[{"name":"Oncologie h\u00e9matologique et th\u00e9rapie cellulaire, CHU Poitiers Poitiers France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Coso","sequence":"additional","affiliation":[{"name":"Department of Hematology Institut Paoli Calmettes Marseille"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Herbaux","sequence":"additional","affiliation":[{"name":"Hematology, H\u00f4pital HURIEZ UAM allogreffe de CSH, CHRU Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Yakoub\u2010Agha","sequence":"additional","affiliation":[{"name":"Hematology, H\u00f4pital HURIEZ UAM allogreffe de CSH, CHRU Lille France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krimo","family":"Bouabdallah","sequence":"additional","affiliation":[{"name":"Haematology, CHU de Bordeaux Bordeaux France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3463-0089","authenticated-orcid":false,"given":"Eric","family":"Durot","sequence":"additional","affiliation":[{"name":"Department of Hematology Centre Hospitalier Universitaire Reims Cedex FRA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gandhi","family":"Damaj","sequence":"additional","affiliation":[{"name":"Institut d'H\u00e9matologie de Basse\u2010Normandie, CHU Caen France"},{"name":"Microenvironnement Cellulaire et Pathologies, Normandie Univ, Unicaen MILPAT Caen 14000 France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,3,14]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)08938-9"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198706113162401"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.3.588"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199512073332305"},{"key":"e_1_2_8_6_1","first-page":"549","article-title":"High\u2010dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen\u2010related toxicity","volume":"15","author":"Besien K","year":"1995","journal-title":"Bone Marrow Transplant."},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V73.1.340.340"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1618"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2014.312"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190500527769"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1703179"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190802340184"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.273"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2006.03.016"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3982.3982"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.2516.2516"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.257"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-596668"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc11454"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2015.02.005"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2016.340"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-015-2866-9"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminoncol.2004.12.014"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.07.024"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2014.916800"},{"key":"e_1_2_8_26_1","first-page":"1","article-title":"Comparison of conditioning regimens of various intensities forallogeneic hematopoietic SCT using HLA\u2010identical sibling donorsin AML and MDS with","author":"Martino R","year":"2012","journal-title":"Bone Marrow Transplant."},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2013.02.013"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2199"},{"issue":"10","key":"e_1_2_8_29_1","first-page":"1357","article-title":"Efficacy of bendamustine in patients with relapsed or refractory chronic lymphocytic leukemia: results of a phase I\/II study of the German CLL Study Group","volume":"90","author":"Bergmann MA","year":"2005","journal-title":"Haematologica."},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-005-0050-z"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1254-8"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6603776"}],"container-title":["American Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fajh.25077","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.25077","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ajh.25077","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ajh.25077","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T07:33:07Z","timestamp":1693899187000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ajh.25077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,14]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1002\/ajh.25077"],"URL":"https:\/\/doi.org\/10.1002\/ajh.25077","archive":["Portico"],"relation":{},"ISSN":["0361-8609","1096-8652"],"issn-type":[{"value":"0361-8609","type":"print"},{"value":"1096-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,14]]}}}